![]() Cronos Group The Cronos Group (formerly known as PharmaCan Capital) is a company that distributes medical cannabis products. | ![]() Aphria Aphria is a company that produces and sells medical and adult-use cannabis and cannabis-derived extracts. | Tilray Brands Tilray Brands (formerly known as Tilray) is a company that engages in the research, cultivation, processing, and distribution of medical cannabis products. | ||||||
Founding Date | Founding Date 2013 | Founding Date 2013 | Founding Date 2016 | Founding Date 2013 | Founding Date 2013 | Founding Date 2013 | Founding Date 2014 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | ||||||||
Locations | Locations Toronto, CA HQ Melbourne, AU Gan Shmuel, IL | Locations Chicago, US HQ | Locations North Fort Myers, US HQ Bradenton, US Edgewater, US Jacksonville, US Miami, US Orlando, US Pensacola, US see more | Locations Ottawa, CA HQ | Locations Moncton, CA HQ Toronto, CA | Locations Leamington, CA HQ | Locations Smiths Falls, CA HQ | |
Employees | Employees 356 | Employees 500 | Employees 4,455 | Employees 822 | Employees 914 | Employees 620107% increase | Employees 1,029 | Employees 2,650 |
Valuation ($) | Valuation ($) 847.6 m | Valuation ($) 534.9 m | Valuation ($) 2.2 b | Valuation ($) 31.2 m | Valuation ($) 201.4 m | Valuation ($) N/A | Valuation ($) 599.5 m | Valuation ($) 1.6 b |
Financial | ||||||||
Revenue (est.) | Revenue (est.) $87.2m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $1.1b (FY, 2023) | Revenue (est.) $191.1m (FY, 2022) | Revenue (est.) $161.6m (FY, 2023) | Revenue (est.) $543.3m (FY, 2020) | Revenue (est.) $297.1m (FY, 2024) | Revenue (est.) $788.9m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $540.6m (FY, 2023) | Cost of goods $283m (FY, 2022) | Cost of goods $136.4m (FY, 2023) | Cost of goods $351.4m (FY, 2020) | Cost of goods $216.3m (FY, 2024) | Cost of goods $565.6m (FY, 2024) |
Gross profit | Gross profit $11.9m (FY, 2023) | Gross profit N/A | Gross profit $588.6m (FY, 2023) | Gross profit ($32.2m) (FY, 2022) | Gross profit $25.2m (FY, 2023) | Gross profit $192m (FY, 2020) | Gross profit $80.9m (FY, 2024) | Gross profit $223.4m (FY, 2024) |
Net income | Net income ($74.6m) (FY, 2023) | Net income N/A | Net income ($533.1m) (FY, 2023) | Net income ($1.1b) (FY, 2022) | Net income ($248.6m) (FY, 2023) | Net income ($84.6m) (FY, 2020) | Net income ($675.8m) (FY, 2024) | Net income ($222.4m) (FY, 2024) |
Operating ⚠ | ||||||||
Brands | Brands 3 (FY, 2022) | Brands N/A | Brands N/A | Brands N/A | Brands 3 (Q1, 2020) | Brands N/A | Brands 13 (FY, 2023) | Brands N/A |
Cannabis Sold, kilogram and kilogram equivalents | Cannabis Sold, kilogram and kilogram equivalents N/A | Cannabis Sold, kilogram and kilogram equivalents N/A | Cannabis Sold, kilogram and kilogram equivalents N/A | Cannabis Sold, kilogram and kilogram equivalents N/A | Cannabis Sold, kilogram and kilogram equivalents 5.5 k (Q1, 2020) | Cannabis Sold, kilogram and kilogram equivalents 13.4 k (FY, 2019) | Cannabis Sold, kilogram and kilogram equivalents N/A | Cannabis Sold, kilogram and kilogram equivalents N/A |
Funding | ||||||||
Total funding raised | Total funding raised $ 1.9b | Total funding raised $ 4.1m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 162.4m | Total funding raised $ 4.6b | Total funding raised $ 55.3m |
Cresco Labs is a medical cannabis cultivation company.
View companyTrulieve is a medical marijuana dispensing organization.
View companyOrganigram is a producer of medical cannabis and cannabis-derived products.
View company